Press "Enter" to skip to content

New patent for Teva Pharm drug AIRDUO RESPICLICK

0
Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug AIRDUO RESPICLICK

Annual Drug Patent Expirations for AIRDUO+RESPICLICK
Annual Drug Patent Expirations for AIRDUO+RESPICLICK

Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from three suppliers. There are twenty-one patents protecting this drug.

Drug patent litigation for AIRDUO RESPICLICK.

This drug has three hundred and sixty patent family members in thirty-six countries.

The generic ingredient in AIRDUO RESPICLICK is fluticasone propionate; salmeterol xinafoate. Three suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug AIRDUO RESPICLICK
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions